IT Spending on Clinical Analytics Market

IT Spending on Clinical Analytics Market (Platform - Stand-alone, Integrated; End User - Payer (Insurance Companies and Government) and Provider (Hospital and Clinics); Solution - In-house (Hardware, Software, and Services), and Outsource; Deployment - Cloud-based and On-premise) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

IT Spending on Clinical Analytics: Global Snapshot

Over the past few decades, there has been a significant transition in the healthcare industry. It has witnessed tremendous growth due to the high demand of value-based care for population health in all parts of the globe and has transformed from a manually-operated sector to a digitally managed one. This synchronization of digital and physical worlds has started generating mammoth volumes of patient data, proper analysis of which can lead to bountiful benefits such as reduction in the numbers of patient readmission in hospitals and improved clinical outcomes, to name a few. Vast improvements in financial and clinical decision support management are also made possible by critical analysis of data generated by healthcare systems.

A greater understanding of these factors, coupled with the rising adoption of digital data management tools in healthcare settings is leading to a vast rise in expenditure on clinical analytics systems and solutions. Transparency Market Research (TMR) estimates that the global IT spending on clinical analytics will rise manifolds in the years to come. According to this report by TMR, IT spending on clinical analytics across the globe valued at US$11,650 mn in 2015. Expanding at a remarkable 12.3% CAGR over the period between 2016 and 2024, this is projected to reach US$32,422 mn by 2024.

it spending on clinical analytics market

Integrated Systems to Dominate Thanks to Flexibility and Capability to Sync with Other Systems

In the report, the IT spending on clinical analytics is segmented on the basis of platform into stand-alone and integrated. Of these, the segment of integrated clinical analytics solutions acquired the dominant chunk of revenues of the global market in 2015 and is expected to maintain dominance over the forecast period as well.

The integrated clinical analytics segment is also expected to exhibit a higher CAGR of 13.1% compared to the segment of stand-alone clinical analytics solutions, which is expected to expand at an 11.0% CAGR, over the period between 2016 and 2024. Of the overall global spending on clinical analytics solutions, spending on integrated solutions is expected to account for a 63% of the global market by 2024.

Integrated clinical analytics solutions observe higher demand owing to their highly dynamic nature and ability to extract data from clinical documents synched with the system, such as (electronic health records) EHR, utilizing the data to generate key insights. The relatively lower level of competency of stand-alone systems in terms of ability to integrate well with other data processing or managing systems will lead to their relatively lower adoption on a global front.

Digitization of Healthcare Infrastructure to Keep North America Ahead in Clinical Analytics Spending

In terms of geography, the market is dominated by North America and the region will continue to constitute the bulk of share in the global market by the end of the forecast period as well. The region leads in terms of IT spending on clinical analytics owing chiefly to the technologically advanced healthcare infrastructure, favorable government policies, and increased incentives. The IT spending on clinical analytics in North America is estimated to be valued at US$5,349 mn by the end of 2016 and is expected to expand at a CAGR of 10.8% to reach US$12,110 mn by 2024.

However, North America is expected to lose to Asia Pacific in terms of rate of growth over the forecast period; IT spending on clinical analytics in Asia Pacific is expected to expand at a remarkable 16.9% by 2024. The region will see the adoption of clinical analytics at such a rapid pace owing to vast technological advancements, enhancement and rapid digitization of healthcare infrastructure, and increased adoption big data and analytics in healthcare. Japan is a highly attractive market in the region, followed by China and India. Other APAC countries are also expected to emerge as highly promising markets for clinical analytics in the next few years owing to similar factors.

Some of the key players in clinical analytics are McKesson Corporation, Cerner Corporation, IBM Corporation, Optum, Inc., Allscripts Healthcare Solutions, Inc., Oracle Financial Services Software Limited, CareCloud Corporation, Medical Information Technology, Inc., Hewlett-Packard Enterprise Development LP and ArborMetrix, Inc.

Advent of Digital Data Analytics to Boost Growth of IT Spending on Clinical Analytics Market

The healthcare sector has witnessed a notable growth in the past few years on account of the advent of digitally managed patient data analytics. It has witnessed enormous development because of the high interest of significant worth based consideration for population wellbeing in all pieces of the globe and has changed from a physically worked area to a digitally oversaw one. This synchronization of digital and physical universes has begun generating mammoth volumes of patient information, legitimate analysis of which can prompt bountiful benefits like reduction in the quantities of patient readmission in hospitals and improved clinical results, to give some examples. Immense improvements in financial and clinical decision support the executives are additionally made possible by critical analysis of information created by medical care frameworks.

Integrated clinical analytics solutions notice higher interest owing to their highly dynamic nature and ability to remove information from clinical reports synchronized with the framework, for example, (electronic wellbeing records) EHR, utilizing the information to create key insights. The relatively lower level of competency of independent frameworks regarding ability to integrate well with other information processing or managing frameworks will prompt their relatively lower adoption on a worldwide front.

Clinical analytics has created groundswell of interest among medical services enterprises in various countries for underpinning the rapid digital transformation in medical care industry in the course of recent years. Rising interest has for some converted into enormous innovation spend. This is a key factor driving the worldwide IT spending on clinical analytics market. Rapid digitization of wellbeing IT infrastructures in created countries has sped up spending on IT spending on clinical analytics.

Growing adoption of medical care enterprises of electronic wellbeing records (EHRs) in various regions across the globe is boosting the IT spending on clinical analytics. EHRs have shown promising potential in reducing medication mistakes, bring significant expense savings, and in improving population wellbeing. Medical services providers have additionally been leveraging the potential of clinical analytics to bring down hospital readmission rates.

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global IT Spending on Clinical Analytics

    4. Market Overview
         4.1. Introduction
                4.1.1. Platform Definition
                4.1.2. Industry Evolution / Developments
         4.2.  Overview
         4.3. Key Market Indicators
         4.4. Key Industry Developments
         4.5. Market Opportunity Map
         4.6. Market Dynamics
                4.6.1. Drivers
                4.6.2. Restraints
                4.6.3. Opportunity
         4.7. Global IT Spending on Clinical Analytics Analysis and Forecasts, 2016–2024
                4.7.1. Market Revenue Projections (US$ Mn)
         4.8. Porter’s Five Force Analysis
         4.9. Clinical Analytics Process Workflow
         4.10. Market Outlook

    5. Global IT Spending on Clinical Analytics Analysis and Forecasts, By Platform 
         5.1. Introduction & Definition
         5.2. Key Findings / Developments     
         5.3. Key Trends
         5.4. Market Value Forecast By Platform, 2016–2024
                5.4.1. Stand-alone
                5.4.2. Integrated
         5.5. Platform Comparison Matrix
         5.6. Market Attractiveness By Platform 

    6. Global IT Spending on Clinical Analytics Analysis and Forecasts, By End User 
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Key Trends
         6.4. Market Value Forecast By End User, 2016–2024
                6.4.1. Payer
                          6.4.1.1. Insurance Companies
                          6.4.1.2. Government
                          6.4.1.3. Others
                6.4.2. Provider
                          6.4.2.1. Hospitals
                          6.4.2.2. Clinics
         6.5. End User Comparison Matrix
         6.6. Market Attractiveness By End User 

    7. Global IT Spending on Clinical Analytics Analysis and Forecasts, By Solution 
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Key Trends
         7.4. Market Value Forecast By Solution, 2016–2024
                7.4.1. In-House
                          7.4.1.1. Hardware
                          7.4.1.2. Software
                          7.4.1.3. Services
                7.4.2. Outsource
         7.5. Solution Comparison Matrix
         7.6. Market Attractiveness By Solution 

    8. Global IT Spending on Clinical Analytics Analysis and Forecasts, By Deployment 
         8.1. Introduction & Definition
         8.2. Key Findings / Developments
         8.3. Key Trends
         8.4. Market Value Forecast By Deployment, 2016–2024
                8.4.1. Cloud-based
                8.4.2. On-premise
         8.5. Deployment Comparison Matrix
         8.6. Market Attractiveness By Deployment 

    9. Global IT Spending on Clinical Analytics Analysis and Forecasts, By Region
         9.1. Key Findings
         9.2. Policies and Regulations
         9.3. Market Value Forecast By Region
                9.3.1. North America 
                9.3.2. Europe 
                9.3.3. Asia Pacific 
                9.3.4. Latin America 
                9.3.5. Middle East and Africa 
         9.4. Market Attractiveness By Country/Region

    10. North America IT Spending on Clinical Analytics Analysis and Forecast
         10.1.Introduction
                10.1.1. Key Findings
                10.1.2. Policies and Regulations
                10.1.3. Price Trend Analysis
                10.1.4. Key Trends
         10.2. Market Value Forecast By Platform, 2016–2024
                10.2.1. Stand-alone
                10.2.2. Integrated
         10.3. Market Value Forecast By End User, 2016–2024
                10.3.1. Payer
                          10.3.1.1. Insurance Companies
                          10.3.1.2. Government
                          10.3.1.3. Others
                10.3.2. Provider
                          10.3.2.1. Hospitals
                          10.3.2.2. Clinics
         10.4. Market Value Forecast By Solution, 2016–2024
                10.4.1. In-House
                          10.4.1.1. Hardware
                          10.4.1.2. Software
                          10.4.1.3. Services
                10.4.2. Outsource
         10.5. Market Value Forecast By Deployment, 2016–2024
                10.5.1. Cloud-based
                10.5.2. On-premise
         10.6. Market Value Forecast By Country, 2016–2024
                10.6.1. U.S.
                10.6.2. Canada
         10.7. Market Attractiveness Analysis 
                10.7.1. By Platform 
                10.7.2. By End User 
                10.7.3. By Solution 
                10.7.4. By Deployment 
                10.7.5. By Country

    11. Europe IT Spending on Clinical Analytics Analysis and Forecast
         11.1. Introduction
                11.1.1. Key Findings
                11.1.2. Policies and Regulations
                11.1.3. Price Trend Analysis
                11.1.4. Key Trends
         11.2. Market Value Forecast By Platform, 2016–2024
                11.2.1. Stand-alone
                11.2.2. Integrated
         11.3. Market Value Forecast By End User, 2016–2024
                11.3.1. Payer
                          11.3.1.1. Insurance Companies
                          11.3.1.2. Government
                          11.3.1.3. Others
                11.3.2. Provider
                          11.3.2.1. Hospitals
                          11.3.2.2. Clinics
         11.4. Market Value Forecast By Solution, 2016–2024
                11.4.1. In-House
                          11.4.1.1. Hardware
                          11.4.1.2. Software
                          11.4.1.3. Services
                11.4.2. Outsource
         11.5. Market Value Forecast By Deployment, 2016–2024
                11.5.1. Cloud-based
                11.5.2. On-premise
         11.6. Market Value Forecast By Country, 2016–2024
                11.6.1. Germany
                11.6.2. U.K.
                11.6.3. France
                11.6.4. Italy
                11.6.5. Spain
                11.6.6. Rest of Europe
         11.7. Market Attractiveness Analysis 
                11.7.1. By Platform 
                11.7.2. By End User 
                11.7.3. By Solution 
                11.7.4. By Deployment 
                11.7.5. By Country

    12. Asia Pacific IT Spending on Clinical Analytics Analysis and Forecast
         12.1. Introduction
                12.1.1. Key Findings
                12.1.2. Policies and Regulations
                12.1.3. Price Trend Analysis
                12.1.4. Key Trends
         12.2. Market Value Forecast By Platform, 2016–2024
                12.2.1. Stand-alone
                12.2.2. Integrated
         12.3. Market Value Forecast By End User, 2016–2024
                12.3.1. Payer
                          12.3.1.1. Insurance Companies
                          12.3.1.2. Government
                          12.3.1.3. Others
                12.3.2. Provider
                          12.3.2.1. Hospitals
                          12.3.2.2. Clinics
         12.4. Market Value Forecast By Solution, 2016–2024
                12.4.1. In-House
                          12.4.1.1. Hardware
                          12.4.1.2. Software
                          12.4.1.3. Services
                12.4.2. Outsource
         12.5. Market Value Forecast By Deployment, 2016–2024
                12.5.1. Cloud-based
                12.5.2. On-premise
         12.6. Market Value Forecast By Country, 2016–2024
                12.6.1. China
                12.6.2. Japan
                12.6.3. India
                12.6.4. Australia
                12.6.5. New Zealand
                12.6.6. Rest of Asia Pacific
         12.7. Market Attractiveness Analysis 
                12.7.1. By Platform 
                12.7.2. By End User 
                12.7.3. By Solution 
                12.7.4. By Deployment 
                12.7.5. By Country

    13. Latin America IT Spending on Clinical Analytics Analysis and Forecast
         13.1. Introduction
                13.1.1. Key Findings
                13.1.2. Policies and Regulations
                13.1.3. Price Trend Analysis
                13.1.4. Key Trends
         13.2. Market Value Forecast By Platform, 2016–2024
                13.2.1. Stand-alone
                13.2.2. Integrated
         13.3. Market Value Forecast By End User, 2016–2024
                13.3.1. Payer
                          13.3.1.1. Insurance Companies
                          13.3.1.2. Government
                          13.3.1.3. Others
                13.3.2. Provider
                          13.3.2.1. Hospitals
                          13.3.2.2. Clinics
         13.4. Market Value Forecast By Solution, 2016–2024
                13.4.1. In-House
                          13.4.1.1. Hardware
                          13.4.1.2. Software
                          13.4.1.3. Services
                13.4.2. Outsource
         13.5. Market Value Forecast By Deployment, 2016–2024
                13.5.1. Cloud-based
                13.5.2. On-premise
         13.6. Market Value Forecast By Country, 2016–2024
                13.6.1. Brazil
                13.6.2. Mexico
                13.6.3. Rest of Latin America
         13.7. Market Attractiveness Analysis 
                13.7.1. By Platform 
                13.7.2. By End User 
                13.7.3. By Solution 
                13.7.4. By Deployment 
                13.7.5. By Country

    14. Middle East and Africa IT Spending on Clinical Analytics Analysis and Forecast
         14.1. Introduction
                14.1.1. Key Findings
                14.1.2. Policies and Regulations
                14.1.3. Price Trend Analysis
                14.1.4. Key Trends
         14.2. Market Value Forecast By Platform, 2016–2024
                14.2.1. Stand-alone
                14.2.2. Integrated
         14.3. Market Value Forecast By End User, 2016–2024
                14.3.1. Payer
                          14.3.1.1. Insurance Companies
                          14.3.1.2. Government
                          14.3.1.3. Others
                14.3.2. Provider
                          14.3.2.1. Hospitals
                          14.3.2.2. Clinics
         14.4. Market Value Forecast By Solution, 2016–2024
                14.4.1. In-House
                          14.4.1.1. Hardware
                          14.4.1.2. Software
                          14.4.1.3. Services
                14.4.2. Outsource
         14.5. Market Value Forecast By Deployment, 2016–2024
                14.5.1. Cloud-based
                14.5.2. On-premise
         14.6. Market Value Forecast By Country, 2016–2024
                14.6.1. Saudi Arabia
                14.6.2. U.A.E
                14.6.3. South Africa
                14.6.4. Rest of Middle East and Africa
         14.7. Market Attractiveness Analysis 
                14.7.1. By Platform 
                14.7.2. By End User 
                14.7.3. By Solution 
                14.7.4. By Deployment 
                14.7.5. By Country

    15. Competition Landscape
         15.1. Major Licenses and Contracts
         15.2. Market Player – Competition Matrix (By Tier and Size of companies)
         15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
                15.3.1. McKesson Corporation
                          15.3.1.1. Company Overview
                          15.3.1.2. Financials
                          15.3.1.3. SWOT Analysis
                          15.3.1.4. Strategic Overview
                15.3.2. Cerner Corporation
                          15.3.2.1. Company Overview
                          15.3.2.2. Financials
                          15.3.2.3. SWOT Analysis
                          15.3.2.4. Strategic Overview
                15.3.3. IBM Corporation
                          15.3.3.1. Company Overview
                          15.3.3.2. Financials
                          15.3.3.3. SWOT Analysis
                          15.3.3.4. Strategic Overview
                15.3.4. Optum, Inc.
                          15.3.4.1. Company Overview
                          15.3.4.2. Financials
                          15.3.4.3. SWOT Analysis
                          15.3.4.4. Strategic Overview
                15.3.5. Allscripts Healthcare Solutions, Inc.
                          15.3.5.1. Company Overview
                          15.3.5.2. Financials
                          15.3.5.3. SWOT Analysis
                          15.3.5.4. Strategic Overview
                15.3.6. Oracle Financial Services Software Limited
                          15.3.6.1. Company Overview
                          15.3.6.2. Financials
                          15.3.6.3. SWOT Analysis
                          15.3.6.4. Strategic Overview
                15.3.7. Medical Information Technology, Inc.
                          15.3.7.1. Company Overview
                          15.3.7.2. Financials
                          15.3.7.3. SWOT Analysis
                          15.3.7.4. Strategic Overview
                15.3.8. Hewlett-Packard Enterprise Development LP
                          15.3.8.1. Company Overview
                          15.3.8.2. Financials
                          15.3.8.3. SWOT Analysis
                          15.3.8.4. Strategic Overview
                15.3.9. Arbormetrix, Inc.
                          15.3.9.1. Company Overview
                          15.3.9.2. Financials
                          15.3.9.3. SWOT Analysis
                          15.3.9.4. Strategic Overview
                15.3.10. CareCloud Corporation
                          15.3.10.1. Company Overview
                          15.3.10.2. Financials
                          15.3.10.3. SWOT Analysis
                          15.3.10.4. Strategic Overview

    List of Tables

    Table 01: Global IT Spending on Clinical Analytics (US$ Mn) Forecast: by Platform, 2016–2024
    Table 02: Global IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User, 2016–2024
    Table 03: Global IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User (Payer), 2016–2024
    Table 04: Global IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User (Provider), 2016–2024
    Table 05: Global IT Spending on Clinical Analytics (US$ Mn) Forecast: by Solution, 2016–2024
    Table 06: Global IT Spending on Clinical Analytics (US$ Mn) Forecast: by Solution, 2016–2024
    Table 07: Global IT Spending on Clinical Analytics (US$ Mn) Forecast: by Deployment, 2016–2024
    Table 08: Global IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Region, 2016-2024
    Table 09: North America IT Spending on Clinical Analytics (US$ Mn) Forecast: by Platform, 2016-2024
    Table 10: North America IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User, 2016–2024
    Table 11: North America IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User (Payer), 2016–2024
    Table 12: North America IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User (Provider), 2016–2024
    Table 13: North America IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Solution, 2016-2024
    Table 14: North America IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Solution, 2016-2024
    Table 15: North America IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Deployment, 2016-2024
    Table 16: North America IT Spending on Clinical Analytics (US$ Mn) Forecast: by Country, 2016-2024
    Table 17: Europe IT Spending on Clinical Analytics (US$ Mn) Forecast: by Platform, 2016-2024
    Table 18: Europe IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by End User, 2016–2024
    Table 19: Europe IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by End User (Payer), 2016–2024
    Table 20: Europe IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by End User (Provider), 2016–2024
    Table 21: Europe IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Solution, 2016–2024
    Table 22: Europe IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Solution (In-House), 2016–2024
    Table 23: Europe IT Spending on Clinical Analytics (US$ Mn) Forecast: by Deployment, 2016–2024
    Table 24: Europe IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Country, 2016-2024
    Table 25: Asia Pacific IT Spending on Clinical Analytics (US$ Mn) Forecast: by Platform, 2016-2024
    Table 26: Asia Pacific IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User, 2016–2024
    Table 27: Asia Pacific IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User (Payer), 2016–2024
    Table 28: Asia Pacific IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User (Provider), 2016–2024
    Table 29: Asia Pacific IT Spending on Clinical Analytics (US$ Mn) Forecast: by Solution, 2016–2024
    Table 30: Asia Pacific IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Solution, 2016–2024
    Table 31: Asia Pacific IT Spending on Clinical Analytics (US$ Mn) Forecast: by Deployment, 2016–2024
    Table 32: Asia Pacific IT Spending on Clinical Analytics (US$ Mn) Forecast: by Country, 2016-2024
    Table 33: Latin America IT Spending on Clinical Analytics (US$ Mn)  Forecast: by Platform, 2016-2024
    Table 34: Asia Pacific IT Spending on Clinical Analytics (US$ Mn) Forecast: by Solution, 2016–2024
    Table 35: Latin America IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Solution, 2016–2024
    Table 36: Asia Pacific IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by End User, 2016–2024
    Table 37: Asia Pacific IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by End User, 2016–2024
    Table 38: Asia Pacific IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User, 2016–2024
    Table 39: Latin America IT Spending on Clinical Analytics (US$ Mn) Forecast: by deployment, 2016–2024
    Table 40: Latin America IT Spending on Clinical Analytics Size (US$ Mn) by Country, 2016–2024
    Table 41: Middle East and Africa IT Spending on Clinical Analytics (US$ Mn) Forecast: by Platform, 2016-2024
    Table 42: Middle East and Africa IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by Solution, 2016–2024
    Table 43: Middle East and Africa IT Spending on Clinical Analytics (US$ Mn) Forecast: by Solution (In-House), 2016–2024
    Table 44: Middle East and Africa IT Spending on Clinical Analytics Size (US$ Mn) Forecast: by End User, 2016–2024
    Table 45: Middle East and Africa IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User (Payer), 2016–2024
    Table 46: Middle East and Africa IT Spending on Clinical Analytics (US$ Mn) Forecast: by End User (Provider), 2016–2024
    Table 47: Middle East and Africa IT Spending on Clinical Analytics (US$ Mn) Forecast: by Deployment, 2016–2024
    Table 48: Middle East & Africa IT Spending on Clinical Analytics (US$ Mn) Forecast: by Country, 2016–2024

    List of Figures

    Figure 01: IT Spending On Clinical Analytics Globally, (US$ Mn) Forecast, 2016–2024
    Figure 02: IT Spending On Clinical Analytics Globally, Absolute $ Opportunity (US$ Mn), 2016?2024
    Figure 03: Global IT Spending on Clinical Analytics Value Share Analysis: by Platform, 2016 and 2024
    Figure 04: Global IT Spending on Stand-Alone Clinical Analytics Platform Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 05: Global IT Spending on Integrated Clinical Analytics Platform Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 06: Global IT Spending on Clinical Analytics Attractiveness Analysis: by Platform
    Figure 07: Global IT Spending on Clinical Analytics Value Share Analysis: by End User, 2016 and 2024
    Figure 08: Global IT Spending on Payer (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 09: Global IT Spending on Provider (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 10: Global IT Spending on Clinical Analytics Attractiveness Analysis: by End User
    Figure 11: Global IT Spending on Insurance Companies (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 12: Global IT Spending on Government (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 13: Global IT Spending on  Others (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 14: Global IT Spending on Clinical Analytics Attractiveness Analysis: by End User (Payer)
    Figure 15: Global IT Spending on Hospitals (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 16: Global IT Spending on Clinics (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 17: Global IT Spending on Clinical Analytics Attractiveness Analysis: by End Users (Provider) 
    Figure 18: Global IT Spending on Clinical Analytics Value Share Analysis: by Solution, 2016 and 2024
    Figure 19: Global IT Spending on In-House (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 20: Global IT Spending on Outsource (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 21: Global IT Spending on Clinical Analytics Attractiveness Analysis: by Solution
    Figure 22: Global IT Spending on Hardware (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 23: Global IT Spending on Software (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 24: Global IT Spending on Services (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 25: Global IT Spending on Clinical Analytics Attractiveness Analysis: by Solution (In-House)
    Figure 26: Global IT Spending on Clinical Analytics Value Share Analysis: by Deployment, 2016 and 2024
    Figure 27: Global IT Spending on cloud-based (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 28: Global IT Spending on on-premise (US$ Mn) and Y-o-Y Growth (%), 2016–2024
    Figure 29: Global IT Spending on Clinical Analytics Attractiveness Analysis: by Deployment
    Figure 30: Global IT Spending on Clinical Analytics Value Share Analysis: by Region, 2016 and 2024
    Figure 31: Global IT Spending on Clinical Analytics Attractiveness Analysis: by Region
    Figure 32: North America IT Spending on Clinical Analytics (US$ Mn) Forecast, 2016-2024
    Figure 33: North America IT Spending on Clinical Analytics & Y-o-Y Growth Projections, 2016-2024
    Figure 34: North America IT Spending on Clinical Analytics Attractiveness Analysis: by Country
    Figure 35: North America IT Spending on Clinical Analytics Value Share Analysis:  by Platform, 2016 and 2024
    Figure 36: North America IT Spending on Clinical Analytics Value Share Analysis: by End User, 2016 and 2024
    Figure 37: North America IT Spending on Clinical Analytics Value Share Analysis:  by Solution, 2016 and 2024
    Figure 38: North America IT Spending on Clinical Analytics Value Share Analysis:  by Deployment, 2016 and 2024
    Figure 39: North America IT Spending on Clinical Analytics Value Share Analysis: by Country, 2016 and 2024
    Figure 40: U.S. IT Spending on Clinical Analytics (US$ Mn) Forecast, 2016-2024
    Figure 41: U.S. IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 42: Canada IT Spending on Clinical Analytics (US$ Mn) Forecast, 2016-2024
    Figure 43: Canada IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 44: North America IT Spending on Clinical Analytics Attractiveness Analysis: by Platform, 2016–2024
    Figure 45: North America IT Spending on Clinical Analytics Attractiveness Analysis: by Solution, 2016–2024
    Figure 46: North America IT Spending on Clinical Analytics Attractiveness Analysis: by Deployment, 2016–2024
    Figure 47: North America IT Spending on Clinical Analytics Attractiveness Analysis: By End user, 2016-2024
    Figure 48: Europe IT Spending on Clinical Analytics (US$ Mn)  Forecast, 2016-2024
    Figure 49: Europe IT Spending on Clinical Analytics Y-o-Y Growth Projections, 2016-2024
    Figure 50: Europe IT Spending on Clinical Analytics Attractiveness Analysis: by Country
    Figure 51: Europe IT Spending on Clinical Analytics Value Share Analysis: by Platform, 2016 and 2024
    Figure 52: Europe IT Spending on Clinical Analytics Value Share Analysis: by End User, 2016 and 2024
    Figure 53: Europe IT Spending on Clinical Analytics Value Share Analysis: by Solution, 2016 and 2024
    Figure 54: Europe IT Spending on Clinical Analytics Value Share Analysis: by Deployment, 2016 and 2024
    Figure 55: Europe IT Spending on Clinical Analytics Value Share Analysis: by Country, 2016 and 2024
    Figure 56: Germany IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 57: Germany IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 58: U.K. IT Spending on Clinical Analytics (US$ Mn) Forecast, 2016-2024
    Figure 59: U.K. IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 60: France IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 61: France IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 62: Italy IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 63: Italy IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 64: Spain IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 65: Spain IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 66: Rest of Europe IT Spending on Clinical Analytics (US$ Mn) Forecast, 2016-2024
    Figure 67: Rest of Europe IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 68: Europe IT Spending on Clinical Analytics Attractiveness Analysis: by Platform, 2016–2024
    Figure 69: Europe IT Spending on Clinical Analytics Attractiveness Analysis: by Solution, 2016–2024
    Figure 70: Europe IT Spending on Clinical Analytics Attractiveness Analysis: by Deployment, 2016–2024
    Figure 71: Europe IT Spending on Clinical Analytics Attractiveness Analysis: by end user, 2016–2024
    Figure 72: IT Spending on Clinical Analytics in Asia Pacific (US$ Mn) Forecast, 2016-2024
    Figure 73: IT Spending on Clinical Analytics in Asia Pacific and Y-o-Y Growth Projections, 2016-2024
    Figure 74: IT Spending on Clinical Analytics in Asia Pacific Attractiveness Analysis: by Country, 2016-2024
    Figure 75: Asia Pacific IT Spending on Clinical Analytics Value Share Analysis: by Platform, 2016 and 2024
    Figure 76: Asia Pacific IT Spending on Clinical Analytics Value Share Analysis: by End User, 2016 and 2024
    Figure 77: Asia Pacific IT Spending on Clinical Analytics Value Share Analysis: by Solution, 2016 and 2024
    Figure 78: Asia Pacific IT Spending on Clinical Analytics Value Share Analysis: by Deployment, 2016 and 2024
    Figure 79: Asia Pacific IT Spending on Clinical Analytics Value Share Analysis: by Country, 2016 and 2024
    Figure 80: China IT Spending on Clinical Analytics (US$ Mn) Forecast, 2016-2024
    Figure 81: China IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 82: Japan IT Spending on Clinical Analytics (US$ Mn) Forecast, 2016-2024
    Figure 83: Japan IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 84: India IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 85: India IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn),  2016-2024
    Figure 86: Australia IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 87: Australia IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn),  2016-2024
    Figure 88: New Zealand IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 89: New Zealand IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 90: Rest of APAC IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 91: Rest of APAC IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 92: Asia Pacific IT Spending on Clinical Analytics Attractiveness Analysis: by Platform, 2016–2024
    Figure 93: Asia Pacific IT Spending on Clinical Analytics Attractiveness Analysis: by Solution, 2016–2024
    Figure 94: Asia Pacific IT Spending on Clinical Analytics Attractiveness Analysis: by Deployment, 2016–2024
    Figure 95: Asia Pacific IT Spending on Clinical Analytics Attractiveness Analysis: by end user, 2016–2024
    Figure 96: Latin America IT Spending on Clinical Analytics (US$ Mn) Forecast, 2016–2024
    Figure 97: Latin America IT Spending on Clinical Analytics & Y-o-Y Growth Projections, 2016–2024
    Figure 98: Latin America Market Attractiveness Analysis: by Country
    Figure 99: Latin America IT Spending on Clinical Analytics Value Share Analysis: by Platform, 2016 and 2024
    Figure 100: Latin America IT Spending on Clinical Analytics Value Share Analysis: by Solution, 2016 and 2024
    Figure 101: Latin America IT Spending on Clinical Analytics Value Share Analysis: by End User, 2016 and 2024
    Figure 102: Latin America IT Spending on Clinical Analytics Value Share Analysis: by Deployment, 2016 and 2024
    Figure 103: Latin America Market Value Share Analysis: by Country, 2016 and 2024
    Figure 104: Brazil IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 105: Brazil IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 106: Mexico IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 107: Mexico IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 108: Rest of LATAM IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 109: Rest of LATAM IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 110: Latin America IT Spending on Clinical Analytics Attractiveness Analysis:by Platform, 2016–2024
    Figure 111: Latin America IT Spending on Clinical Analytics Attractiveness Analysis: by Deployment, 2016–2024
    Figure 112: Latin America IT Spending on Clinical Analytics Attractiveness Analysis: by Solution, 2016–2024
    Figure 113: Latin America IT Spending on Clinical Analytics Attractiveness Analysis: by end user, 2016–2024
    Figure 114: MEA Clinical Analytics Market Size (US$ Mn) and Volume (Units) Forecast, 2016–2024
    Figure 115: MEA Clinical Analytics Market Size and Y-o-Y Growth Projections, 2016–2024
    Figure 116: MEA Clinical Analytics Market Attractiveness Analysis: by Country
    Figure 117: Middle East and Africa IT Spending on Clinical Analytics Value Share Analysis: by Product,2016 and 2024
    Figure 118: Middle East and Africa IT Spending on Clinical Analytics Value Share Analysis: by Solution,2016 and 2024
    Figure 119: Middle East and Africa IT Spending on Clinical Analytics Value Share Analysis: by End User,2016 and 2024
    Figure 120: Middle East and Africa IT Spending on Clinical Analytics Value Share Analysis: by Deployment, 2016 and 2024
    Figure 121: Middle East and Africa Market Value Share Analysis: by Country, 2016 and 2024
    Figure 122: Saudi Arabia IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 123: Saudi Arabia IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 124: UAE IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 125: UAE IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 126: RSA IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 127: RSA IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn), 2016-2024
    Figure 128: Rest of MEA IT Spending on Clinical Analytics Size (US$ Mn) Forecast, 2016-2024
    Figure 129: Rest of MEA IT Spending on Clinical Analytics Absolute $ Opportunity (US$ Mn),  2016-2024
    Figure 130: MEA IT Spending on Clinical Analytics Attractiveness Analysis: by Platform, 2016–2024
    Figure 131: MEA IT Spending on Clinical Analytics Attractiveness Analysis: by Solution, 2016–2024
    Figure 132: MEA IT Spending on Clinical Analytics Attractiveness Analysis: by Deployment, 2016–2024
    Figure 133: MEA IT Spending on Clinical Analytics Attractiveness Analysis: by end user, 2016–2024

Copyright © Transparency Market Research, Inc. All Rights reserved